Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MDXG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 145.72M
March 31, 2026 148.93M
December 31, 2025 148.09M
September 30, 2025 148.08M
June 30, 2025 147.92M
March 31, 2025 147.61M
December 31, 2024 146.93M
September 30, 2024 146.96M
June 30, 2024 146.75M
March 31, 2024 147.53M
December 31, 2023 146.23M
September 30, 2023 116.36M
June 30, 2023 116.11M
March 31, 2023 115.38M
December 31, 2022 113.71M
September 30, 2022 113.67M
June 30, 2022 113.61M
March 31, 2022 113.35M
December 31, 2021 111.93M
September 30, 2021 111.93M
June 30, 2021 111.88M
March 31, 2021 111.62M
December 31, 2020 110.93M
September 30, 2020 110.59M
June 30, 2020 110.29M
Date Value
March 31, 2020 110.54M
December 31, 2019 110.82M
September 30, 2019 110.99M
June 30, 2019 111.55M
March 31, 2019 108.87M
December 31, 2018 109.10M
September 30, 2018 109.86M
June 30, 2018
March 31, 2018
December 31, 2017 109.35M
September 30, 2017 111.04M
June 30, 2017 112.46M
March 31, 2017 110.84M
December 31, 2016 109.86M
September 30, 2016 109.51M
June 30, 2016 110.02M
March 31, 2016 109.47M
December 31, 2015 107.36M
September 30, 2015 109.04M
June 30, 2015 108.90M
March 31, 2015 108.49M
December 31, 2014 107.79M
September 30, 2014 106.89M
June 30, 2014 105.33M
March 31, 2014 105.79M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 13.38M
Perspective Therapeutics, Inc. 114.09M
ABVC BioPharma, Inc. 25.77M
Enovis Corp. 57.67M
Edwards Lifesciences Corp. 576.60M